A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

329

Participants

Timeline

Start Date

November 16, 2018

Primary Completion Date

July 29, 2019

Study Completion Date

August 22, 2019

Conditions
Atopic Dermatitis
Interventions
DRUG

Baricitinib

Administered orally.

DRUG

Topical corticosteroid

Administered as standard-of-care.

DRUG

Placebo

Administered orally.

Trial Locations (68)

333

Chang Gung Memorial Hospital - Linkou, Taoyuan, (r.o.c.)

2145

Skin & Cancer Foundation Australia, Westmead

2606

Woden Dermatology, Phillip

3053

Skin and Cancer Foundation Inc., Melbourne

4102

Veracity Clinical Research Pty Ltd, Woolloongabba

4217

The Skin Centre, Benowa

5073

Clinical Trials SA Pty Ltd, Adelaide

5500

Parra Dermatología, Mendoza

6160

Fremantle Dermatology, Perth

8036

Universitätsklinikum Graz, Graz

10048

National Taiwan University Hospital, Taipei

10117

Charité Universitätsmedizin Berlin, Berlin

10326

Dongguk University Ilsan Hospital, Goyang-si

10508

Chang Gung Memorial Hospital - Taipei, Taipei

14004

Hospital Reina Sofia, Córdoba

15355

Korea University Ansan Hospital, Ansan-si

16132

Azienda Ospedaliera Universitaria Ospedale San Martino di Genova, Genova

20089

Istituto Clinico Humanitas, Rozzano

20537

TFS Trial Form Support GmbH, Hamburg

21565

Gachon University Gil Medical Center, Incheon

23538

Universitätsklinikum Schleswig-Holstein, Lübeck

23561

Taipei Medical University- Shuang Ho Hospital, New Taipei City

28034

Hospital Universitario Ramon y Cajal, Madrid

35010

Hospital De Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria

36100

ULSS 8 UOC Dermatologia Viale Rodolfi, 37, Vicenza

40201

Chung Shan Medical University Hospital, Taichung

45147

Universitaetsklinikum Essen, Essen

48149

Universitätsklinikum Münster, Münster

49565

Dermatologisches Zentrum Osnabrück Nord, Bramsche

52074

Universitätsklinikum Aachen - UKA, Aachen

56126

Azienda Ospedaliera - Universitaria Pisana, Pisa

64283

Rosenpark Research Geschäftsbereich der Rosenparkklinik GmbH, Darmstadt

69120

Universitätsklinikum Heidelberg, Heidelberg

80337

Klinikum der Universität München, München

83301

Chang Gung Memorial Hospital - Kaohsiung, Kaohsiung City

9330871

Shirasaki Clinic, Takaoka-shi

C1056ABJ

Centro de Investigaciones Metabólicas (CINME) - Comite, Ciudad Autonoma Buenos Aires

C1121ABE

Fundacion CIDEA, Ciudad Autonoma Buenos Aires

C1425BEA

Instituto de Neumonología y Dermatología, Ciudad Autonoma Buenos Aires

C1425DKG

Psoriahue Medicina Interdisciplinaria, Ciudad Autonoma Buenos Aires

00168

Policlinico Univ. Agostino Gemelli, Rome

272-0033

Kawashima Dermatology Clinic, Ichikawa-shi

271-0092

Medical Corporation Soleil Miyata Dermatology Clinic, Matsudo-shi

818-0104

Yamano Dermatological Clinic, Dazaifu

820-0040

Tashiro Dermatological Clinic, Iizuka

006 0022

Shibaki Dermatology Clinic, Sapporo

060-0063

Sapporo Skin Clinic, Sapporo

220-6208

Queen's Square Dermatology and Allergology, Nishi-ku, Yokohama-city

572-0838

Yoshioka Dermatology Clinic, Neyagawa

560-0085

Senri-Chuo Hanafusa Dermatology Clinic, Toyonaka-shi

430-0929

JA Shizuoka Kohseiren Enshu Hospital, Hamamatsu

102-0072

Iidabashi Clinic, Chiyoda-ku

102-8798

Tokyo Teishin Hospital, Chiyoda-Ku

104-0031

Hosono Clinic, Chuo-ku

178-0063

Oizumi Hanawa Clinic, Nerima-ku

169-0075

Yamate Dermatological Clinic, Shinjuku

190-0023

Tachikawa Dermatology Clinic, Tachikawa-shi

90-265

Dermed Centrum Medyczne Sp. z o.o., Lodz

21-040

Lubelskie Centrum Diagnostyczne, Świdnik

01-518

Centrum Medyczne AMED, Warsaw

02-625

Centrum Medyczne Evimed, Warsaw

03722

Severance Hospital Yonsei University Health System, Seoul

05030

Konkuk University Hospital, Seoul

06591

Seoul St. Mary's Hospital, Seoul

06973

Chungang University Hospital, Seoul

07441

Hallym University Kangnam Sacred Heart Hospital, Seoul

08003

Hospital del Mar, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Incyte Corporation

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT03733301 - A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter